GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Boston Scientific Corporation (BSX) [hlAlert]

Rating:
Sell BSX
down 26.15 %

Boston Scientific Corporation (BSX) rated Sell

Posted on: Thursday,  Dec 13, 2007  8:25 AM ET by Friedman Billings

Friedman Billings rated Sell Boston Scientific Corporation (NYSE: BSX) on 12/13/2007, when the stock price was $12.51. Since
then, Boston Scientific Corporation has gained 35.41% as of 10/28/2015's recent price of $16.94.
If you would have followed this Friedman Billings's recommendation on BSX, you would have lost 26.15% of your investment in 2876 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

FBR Capital Markets is a full service investment banking, institutional sales, trading and research and asset management firm with a customer-focused and innovative approach to meeting its clients needs. It focuses its banking, advisory, trading and research efforts on seven broad industry sectors including consumer, diversified industrials, energy & natural resources, financial institutions, insurance, real estate and technology, media & telecom. With our headquarters in the Washington, D.C. metropolitan area, our Economic and Washington Policy Analysis groups offer clients a comprehensive overview of national economic trends along with a unique perspective on the impact that legislation and regulation will have on industry sectors and individual companies
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/13/2007 8:25 AM Sell
None
12.51 9.00
as of 8/27/2015
1 Week down  -0.41 %
1 Month up  5.62 %
3 Months up  5.41 %
1 YTD down  -40.93 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy